Third Surgeon In US Implants Lenstec ClearView 3 Multifocal IOL
A big congratulations today to Dr. Morgan Micheletti, Berkeley Eye Center (Houston, TX), on being the third surgeon in the U.S. to commercially implant the Lenstec SBL-3 ClearViewTM Multifocal, a NEXT GENERATION presbyopia correcting IOL. Dr. Micheletti continues to be on the forefront of new technology and stated “The ClearView IOL is simple to insert and lives up…
Read More
First FDA Approved ClearView 3 Multifocal Intraocular Lens Implanted In U.S.
Lenstec, Inc. (St. Petersburg, FL) is proud to announce today, that the first U.S. commercial implantations of their newly FDA approved SBL-3 ClearViewTM Multifocal Intraocular lens (MIOL) were performed by Jeff Whitsett, MD of Whitsett Vision (Houston, TX). The SBL-3 Clearview Multifocal is a next generation presbyopia correcting IOL design, that in FDA clinical trials provided…
Read More
Press Release: Lenstec ClearView 3 Multifocal Intraocular Lens For Cataract Surgery Approved By FDA For Sale In The US
The Lenstec ClearView 3 IOL is a next-generation asymmetric multifocal refractive IOL which provides patients with near, intermediate and distance vision. Its patented design allows for improved contrast sensitivity and minimized halo and glare (dysphotopsias) commonly associated with other traditional ‘concentric ring’ multifocal IOLs. The segmented optic design is the first of its kind in…
Read More
SBL-3 Clinical Data Results Discussion At ASCRS
Drs. Chu, Whitsett, and Loden were speaking of the SBL-3 Clinical Data results during the ASCRS in Las Vegas.
Read More
Softec HD Lens Implanted In Young Patient With Soft Cataract
Dr. Justin Spaulding, who implants our Softec HD Lenses, using our Softec HD in a young patient with soft cataracts.
Read More
Lenstec Submits SBL3 IOL For Pre-Market Approval
St. Petersburg, FL. March 16, 2020 Lenstec Inc. has announced its submission of the SBL- 3 IOL for Pre – Market Approval in the U.S. The Lenstec SBL – 3 IOL (Segmented Bi-Focal Lens) is an asymmetric multifocal refractive IOL utilizing a 3 diopter add with a transition zone connecting the distance and near segments….
Read More
Lenstec Completes FDA Trials Of SBL-3
Lenstec announced that it has completed its FDA trial for the SBL-3 IOL (Segmented Bifocal Lens), an asymmetric multifocal refractive IOL designed to provide patients with superior near, intermediate, and distance vision. It also offers improved contrast sensitivity and minimizes halos and glare (dsyphotopsias) commonly associated with other traditional multifocal-presbyopia correcting IOLs, according to a…
Read More
Lenstec Inc. Has Announced That It Has Completed Enrollment Of The FDA Trial For The SBL-3 IOL.
Lenstec Inc. has announced that it has completed enrollment of the FDA trial for the SBL-3 IOL.The Lenstec SBL – 3 IOL (Segmented Bi Focal Lens) is a non-concentric asymmetric multifocal refractive IOL. It provides patients with superior near, intermediate and distance vision. It also improves contrast sensitivity, and minimizes the halos and glare, (dsyphotopsias)…
Read More